Highlights
IIA supported (ever)1 patent
About
Genomics Sequencing Technology
Ultima Genomics is focused on driving the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company’s new sequencing architecture lowers the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information.
Ultima’s new sequencing architecture is designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information, and catalyze the next phase of genomics in the 21st century.
Identity
| Name | Ultima Genomics |
|---|---|
| Slug | ultima-genomics |
| Type / kind | startup |
| Source _id | LcdLItk8VVi2ag63K5wMXD7eYRdjEkonV64sabHZfsTKVyjBrIxFya |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country | United States |
|---|---|
| HQ country code | US |
| HQ city | Newark |
| HQ address | Newark, CA 94560, USA |
Web & social
| Website | https://www.ultimagenomics.com/ |
|---|---|
| Careers page | https://www.ultimagenomics.com/careers |
| https://www.linkedin.com/company/81904307 | |
| Twitter / X | https://mobile.twitter.com/ultimagenomics |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningDrugs Discovery & Development
Technologies
BiologicalsGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business models
B2B
Tags
machine-learningdiagnosticsgeneticsgenome-editingbiotechnology
Funding
| Total raised | $604.2M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}